Lung cancer is the most common cause of cancer-related death worldwide, with the highly malignant small cell lung cancer having the worst prognosis. In recent years the surge of immunotherapy has given cancer sufferers new hope.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65511-issels-integrative-immunotherapy-non-toxic-treatment-lung-cancer
They say it’s the thought that counts. However, more than half of all holiday shoppers are expected to return gifts, according to a recent national survey. Fortunately, Wahl, a leader in men’s grooming and personal care, has a holiday lineup designed with staying power. The company’s latest offerings consist of budget-friendly gifts for everyone on the list, including new lithium-ion-powered grooming tools, temperature-therapy massage solutions and odor-fighting products for pets.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64839-wahl-holiday-lineup-men-s-grooming-and-personal-care
Lung cancer is the most common cause of cancer-related death worldwide, with the highly malignant small cell lung cancer having the worst prognosis. In recent years the surge of immunotherapy has given cancer sufferers new hope.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64826-issels-recurrent-lung-cancer-responds-to-integrative-immunotherapy
Three and a half years after beginning a clinical trial which demonstrated the first successful and sustained use of genetically engineered T cells to fight leukemia, a research team from the Perelman School of Medicine at the University of Pennsylvania and the Children’s Hospital of Philadelphia will today announce the latest results of studies involving both adults and children with advanced blood cancers that have failed to respond to standard therapies. The findings from the first 59 patients who received this investigational, personalized cellular therapy, known as CTL019, will be presented during the American Society of Hematology’s Annual Meeting and Exposition in New Orleans.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64691-penn-medicine-reports-research-leukemia-patients-cellular-therapy-ctl019
Nearly 90 percent of children and adults with a highly aggressive form of acute lymphoblastic leukemia (ALL) showed no evidence of cancer after receiving a novel, personalized cell therapy that reprograms a patient’s immune system. In pilot studies of bioengineered T cells that attack leukemia, 24 of 27 patients (89%) experienced complete responses within 28 days after treatment. In all, 27 patients received the treatment--22 children treated at The Children’s Hospital of Philadelphia and five adults treated at the Hospital of the University of Pennsylvania.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64394-chop-penn-harness-engineered-t-cells-eliminate-tumors-in-blood-leukemia
In recent years there has been a shift in the understanding of cancer. Immunotherapy with vaccines has been emerging as the most promising direction towards a decisive improvement of treatment outcomes.
The Dendritic Cell Vaccine has received FDA approval for prostate cancer and trials are now under way for a variety of other cancers. These vaccines are usually administered on their own.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64654-issels-integrative-immunotherapy-for-standard-therapy-resistant-cancers
Philips Respironics, a unit of Royal Philips (NYSE: PHG, AEX: PHIA) and a pioneer in science-based sleep solutions, brings a new comfort option to its best-selling, most comfortable full face mask that fits most patients. The Amara gel cushion option is part of a groundbreaking series of new masks and services that are setting a new standard for patient care.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64501-philips-respironics-amara-gel-cushion-face-mask-sleep-apnea
To mark National Massage Therapy Awareness Week (NMTAW), October 20-26, the American Massage Therapy Association (AMTA) has compiled research that suggests symptoms of stress, anxiety and depression (all associated with mental health) may be alleviated with massage therapy.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63936-amta-massage-therapy-research-roundup-mental-health-benefits
Nucletron, an Elekta company, and the world leader in brachytherapy, has launched Esteya®, a new approach for treating patients with skin cancer.
Over the last 30 years, more people were diagnosed with skin cancer worldwide than all other cancers combined, making it the most common type of cancer1. This represents a challenge for health care providers in the years to come. With a cure rate of more than 95 percent2, electronic brachytherapy offers a refined treatment modality with excellent cosmesis.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62823-elekta-nucletron-esteya-electronic-brachytherapy-treating-skin-cancer
Check out Lori Copeland\'s journey about teaching massage therapy at centennial college. Get more information about massage therapy program at http://www.centennialcollege.ca/Programs/ProgramOverview.aspx?Program=5110
CLEAR MEN SCALP THERAPY™ has signed on as a sponsor for the ESPY awards, airing tonight, showing men how the pros look good both on and off the sports field. The brand enlisted football player Tony Gonzalez who has been in training to be the perfect man on the red carpet, as well as the stage, in his new role as a presenter for the 2013 ESPY Awards on behalf of CLEAR. To get in shape for the show, Tony has been using the “2 in 1” shampoo + conditioners and shampoos designed specifically for men to be sure he keeps his tux flake-free all night long (visible flakes with regular use).
To view Multimedia News Release, go to http://www.multivu.com/mnr/62546-clear-men-scalp-therapy-espn-tony-gonzalez-espy-segment
In hopes of women beating bad hair days once and for all, Dove® Hair gives women a great hair day by introducing the NEW Dove® Daily Moisture and NEW Dove® Intensive Repair formulas at the Dove® Great Hair Affair. Show-off your great hair day at www.Dove.com/GreatHairAffair for a chance to win prizes.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62444-dove-great-hair-affair-new-dove-daily-moisture-new-dove-intensive-repair
